Patents Represented by Attorney Kenneth K. Sharples
-
Patent number: 7960144Abstract: Provided are methods of assaying and improving protein folding using circular permutants of fluorescent proteins, including circular permutants of GFP variants and combinations thereof. The invention further provides various nucleic acid molecules and vectors incorporating such nucleic acid molecules, comprising polynucleotides encoding fluorescent protein circular permutants derived from superfolder GFP, which polynucleotides include an internal cloning site into which a heterologous polynucleotide may be inserted in-frame with the circular permutant coding sequence, and which when expressed are capable of reporting on the degree to which a polypeptide encoded by such an inserted heterologous polynucleotide is correctly folded by correlation with the degree of fluorescence exhibited.Type: GrantFiled: June 24, 2008Date of Patent: June 14, 2011Assignee: Los Alamos National Security, LLCInventors: Geoffrey S. Waldo, Stephanie Cabantous
-
Patent number: 7955821Abstract: The invention provides a protein labeling and detection system based on self-complementing fragments of fluorescent and chromophoric proteins. The system of the invention is exemplified with various combinations of self-complementing fragments derived from Aequorea victoria Green Fluorescent Protein (GFP), which are used to detect and quantify protein solubility in multiple assay formats, both in vitro and in vivo.Type: GrantFiled: October 25, 2004Date of Patent: June 7, 2011Assignee: Los Alamos National Security, LLCInventors: Geoffrey S. Waldo, Stephanie Cabantous
-
Patent number: 7910700Abstract: Thermostable fluorescent proteins (TSFPs), methods for generating these and other stability-enhanced proteins, polynucleotides encoding such proteins, and assays and method for using the TSFPs and TSFP-encoding nucleic acid molecules are provided. The TSFPs of the invention show extremely enhanced levels of stability and thermotolerance. In one case, for example, a TSFP of the invention is so stable it can be heated to 99° C. for short periods of time without denaturing, and retains 85% of its fluorescence when heated to 80° C. for several minutes. The invention also provides a method for generating stability-enhanced variants of a protein, including but not limited to fluorescent proteins.Type: GrantFiled: December 19, 2008Date of Patent: March 22, 2011Assignee: Los Alamos National Security, LLCInventors: Andrew M. Bradbury, Geoffrey S. Waldo, Csaba Kiss
-
Patent number: 7910309Abstract: The invention provides highly sensitive and specific assays for the major citrus pathogens Xylella fastidiosa and Xanthomonas axonopodis, including a field deployable multiplexed assay capable of rapidly assaying for both pathogens simultaneously. The assays are directed at particular gene targets derived from pathogenic strains that specifically cause the major citrus diseases of citrus variegated chlorosis (Xylella fastidiosa 9a5c) and citrus canker (Xanthomonas axonopodis pv citri). The citrus pathogen assays of the invention offer femtomole sensitivity, excellent linear dynamic range, and rapid and specific detection.Type: GrantFiled: July 31, 2008Date of Patent: March 22, 2011Assignee: Los Alamos National Security, LLCInventors: R. Bruce Cary, Christopher J. Stubben
-
Patent number: 7868152Abstract: The invention provides anti-sulfotyrosine specific antibodies capable of detecting and isolating polypeptides that are tyrosine-sulfated. The sulfotyrosine antibodies and antibody fragments of the invention may be used to discriminate between the non-sulfated and sulfated forms of such proteins, using any number of immunological assays, such ELISAs, immunoblots, Western Blots, immunoprecipitations, and the like. Using a phage-display system, single chain antibodies (scFvs) were generated and screened against tyrosine-sulfated synthetic peptide antigens, resulting in the isolation of scFvs that specifically recognize sulfotyrosine-containing peptides and/or demonstrate sulfotyrosine-specific binding in tyrosine sulfated proteins. The VH and VL genes from one such sulfotyrosine-specific scFv were employed to generate a full length, sulfotyrosine-specific immunoglobulin.Type: GrantFiled: September 15, 2009Date of Patent: January 11, 2011Assignee: Los Alamos National Security, LLCInventors: Carolyn R. Bertozzi, John Kehoe, Andrew M. Bradbury
-
Patent number: 7846708Abstract: The present invention describes a method for increasing the survival of the bacteria of Rhizobium genus, comprising the steps of: making the bacteria to grow in a chemically defined medium; keeping the bacteria in growth stationary phase for a proper period of time; exposing the bacteria to effective quantities of indole-3-acetic acid (IAA). Within the invention scope there is an alternative method to increase the survival of the bacteria of the Rhizobium genus by means of genetic engineering comprising the steps of: making a recombinant vector codifying enzymes able to produce IAA to express in effective way in said bacteria; making the bacteria to grow in chemically defined culture medium; keeping the bacteria in growth stationary phase for a proper period of time.Type: GrantFiled: June 13, 2006Date of Patent: December 7, 2010Assignee: Consiglo Nazionale delle RicherchInventor: Roberto Defez
-
Patent number: 7666606Abstract: The invention provides a protein labeling and interaction detection system based on engineered fragments of fluorescent and chromophoric proteins that require fused interacting polypeptides to drive the association of the fragments, and further are soluble and stable, and do not change the solubility of polypeptides to which they are fused. In one embodiment, a test protein X is fused to a sixteen amino acid fragment of GFP (?-strand 10, amino acids 198-214), engineered to not perturb fusion protein solubility. A second test protein Y is fused to a sixteen amino acid fragment of GFP (?-strand 11, amino acids 215-230), engineered to not perturb fusion protein solubility. When X and Y interact, they bring the GFP strands into proximity, and are detected by complementation with a third GFP fragment consisting of GFP amino acids 1-198 (strands 1-9).Type: GrantFiled: December 5, 2005Date of Patent: February 23, 2010Assignee: Los Alamos National Security, LLCInventors: Geoffrey S. Waldo, Stephanie Cabantous
-
Patent number: 7589182Abstract: The invention provides anti-sulfotyrosine specific antibodies capable of detecting and isolating polypeptides that are tyrosine-sulfated. The sulfotyrosine antibodies and antibody fragments of the invention may be used to discriminate between the non-sulfated and sulfated forms of such proteins, using any number of immunological assays, such ELISAs, immunoblots, Western Blots, immunoprecipitations, and the like. Using a phage-display system, single chain antibodies (scFvs) were generated and screened against tyrosine-sulfated synthetic peptide antigens, resulting in the isolation of scFvs that specifically recognize sulfotyrosine-containing peptides and/or demonstrate sulfotyrosine-specific binding in tyrosine sulfated proteins. The VH and VL genes from one such sulfotyrosine-specific scFv were employed to generate a full length, sulfotyrosine-specific immunoglobulin.Type: GrantFiled: September 12, 2007Date of Patent: September 15, 2009Assignee: Los Alamos National Security, LLCInventors: Carolyn R. Bertozzi, John Kehoe, Andrew M. Bradbury
-
Patent number: 7585636Abstract: The invention provides protein subcellular localization assays using split fluorescent protein systems. The assays are conducted in living cells, do not require fixation and washing steps inherent in existing immunostaining and related techniques, and permit rapid, non-invasive, direct visualization of protein localization in living cells. The split fluorescent protein systems used in the practice of the invention generally comprise two or more self-complementing fragments of a fluorescent protein, such as GFP, wherein one or more of the fragments correspond to one or more beta-strand microdomains and are used to “tag” proteins of interest, and a complementary “assay” fragment of the fluorescent protein. Either or both of the fragments may be functionalized with a subcellular targeting sequence enabling it to be expressed in or directed to a particular subcellular compartment (i.e., the nucleus).Type: GrantFiled: December 5, 2005Date of Patent: September 8, 2009Assignee: Los Alamos National Security, LLCInventors: Geoffrey S. Waldo, Stephanie Cabantous
-
Patent number: 7432419Abstract: Chimeric anti-microbial proteins, compositions, and methods for the therapeutic and prophylactic treatment of plant diseases caused by the bacterial pathogen Xylella fastidiosa are provided. The anti-microbial proteins of the invention generally comprise a surface recognition domain polypeptide, capable of binding to a bacterial membrane component, fused to a bacterial lysis domain polypeptide, capable of affecting lysis or rupture of the bacterial membrane, typically via a fused polypeptide linker. In particular, methods and compositions for the treatment or prevention of Pierce's disease of grapevines are provided. Methods for the generation of transgenic Vitus vinefera plants expressing xylem-secreted anti-microbial chimeras are also provided.Type: GrantFiled: May 14, 2004Date of Patent: October 7, 2008Assignee: Los Alamos National Security, LLCInventor: Goutam Gupta
-
Patent number: 7390640Abstract: Provided are methods of assaying and improving protein folding using circular permutants of fluorescent proteins, including circular permutants of GFP variants and combinations thereof. The invention further provides various nucleic acid molecules and vectors incorporating such nucleic acid molecules, comprising polynucleotides encoding fluorescent protein circular permutants derived from superfolder GFP, which polynucleotides include an internal cloning site into which a heterologous polynucleotide may be inserted in-frame with the circular permutant coding sequence, and which when expressed are capable of reporting on the degree to which a polypeptide encoded by such an inserted heterologous polynucleotide is correctly folded by correlation with the degree of fluorescence exhibited.Type: GrantFiled: February 22, 2006Date of Patent: June 24, 2008Assignee: Los Alamos National Security, LLCInventors: Geoffrey S. Waldo, Stephanie Cabantous
-
Patent number: 7303894Abstract: Detection of phenols using engineered bacteria. A biosensor can be created by placing a reporter gene under control of an inducible promoter. The reporter gene produces a signal when a cognate transcriptional activator senses the inducing chemical. Creation of bacterial biosensors is currently restricted by limited knowledge of the genetic systems of bacteria that catabolize xenobiotics. By using mutagenic PCR to change the chemical specificity of the Pseudomonas species CF600 DmpR protein, the potential for engineering novel biosensors for detection of phenols has been demonstrated. DmpR, a well-characterized transcriptional activator of the P. CF600's dmp operon mediates growth on simple phenols. Transcription from Po, the promoter heading the dmp operon, is activated when the sensor domain of DmpR interacts with phenol and mono-substituted phenols.Type: GrantFiled: September 18, 2003Date of Patent: December 4, 2007Assignee: Los Alamos National SecurityInventors: Arlene A. Wise, Cheryl R. Kuske, Thomas C. Terwilliger
-
Patent number: 7273964Abstract: A non-human transgenic animal that is transgenic for an antibody or fragments thereof and having a phenotype reminiscent of human pathology. The human pathology includes neurodegenerative syndromes, muscular atrophy/dystrophy and immune disorders. The animals may be used in a method for early diagnosis of neurodegenerative diseases. The method includes monitoring the occurrence of the tau hyperphosphorylation and/or amyloid deposition in the back or lower limb skeletal muscle sample of a subject. Cells are derivable from the non-human transgenic animal and secreting the transgenic antibody. The cells are used for the selection of molecules pharmacologically effective in neurodegenerative and/or muscular pathologies and/or immune disorders.Type: GrantFiled: July 28, 2000Date of Patent: September 25, 2007Assignee: Scuola Internazionale Superiore Di Studi AvanzatiInventors: Antonino Cattaneo, Simona Capsoni, Francesca Ruberti
-
Patent number: 7271241Abstract: The current invention provides methods of improving folding of polypeptides using a poorly folding domain as a component of a fusion protein comprising the poorly folding domain and a polypeptide of interest to be improved. The invention also provides novel green fluorescent proteins (GFPs) and red fluorescent proteins that have enhanced folding properties.Type: GrantFiled: April 24, 2003Date of Patent: September 18, 2007Assignee: Los Alamos National Security, LLCInventor: Geoffrey S. Waldo
-
Patent number: 7179602Abstract: The present invention is directed to a PCR-based method of cycle sequencing DNA and other polynucleotide sequences having high CG content and regions of high GC content, and includes for example DNA strands with a high Cytosine and/or Guanosine content and repeated motifs such as CCT repeats.Type: GrantFiled: September 4, 2003Date of Patent: February 20, 2007Assignee: Los Alamos National Security, LLCInventor: Donna L. Robinson
-
Patent number: 7153656Abstract: Methods for rapidly detecting single or multiple sequence alleles in a sample nucleic acid are described. Provided are all of the oligonucleotide pairs capable of annealing specifically to a target allele and discriminating among possible sequences thereof, and ligating to each other to form an oligonucleotide complex when a particular sequence feature is present (or, alternatively, absent) in the sample nucleic acid. The design of each oligonucleotide pair permits the subsequent high-level PCR amplification of a specific amplicon when the oligonucleotide complex is formed, but not when the oligonucleotide complex is not formed. The presence or absence of the specific amplicon is used to detect the allele. Detection of the specific amplicon may be achieved using a variety of methods well known in the art, including without limitation, oligonucleotide capture onto DNA chips or microarrays, oligonucleotide capture onto beads or microspheres, electrophoresis, and mass spectrometry.Type: GrantFiled: January 3, 2003Date of Patent: December 26, 2006Assignee: Los Alamos National Security, LLCInventors: John P. Nolan, P. Scott White
-
Patent number: 6773918Abstract: Detection of phenols using engineered bacteria. A biosensor can be created by placing a reporter gene under control of an inducible promoter. The reporter gene produces a signal when a cognate transcriptional activator senses the inducing chemical. Creation of bacterial biosensors is currently restricted by limited knowledge of the genetic systems of bacteria that catabolize xenobiotics. By using mutagenic PCR to change the chemical specificity of the Pseudomonas species CF600 DmpR protein, the potential for engineering novel biosensors for detection of phenols has been demonstrated. DmpR, a well-characterized transcriptional activator of the P. CF600's dmp operon mediates growth on simple phenols. Transcription from Po, the promoter heading the dmp operon, is activated when the sensor domain of DmpR interacts with phenol and mono-substituted phenols.Type: GrantFiled: March 8, 2000Date of Patent: August 10, 2004Assignee: The Regents of the University of CaliforniaInventors: Arlene A. Wise, Cheryl R. Kuske, Thomas C. Terwilliger
-
Patent number: 6403078Abstract: Methods and compositions for the prevention and treatment of preterm labor and premature rupture of fetal membranes are provided. The methods of the invention inhibit the upregulated production of certain pro-inflammatory cytokines in amniochorionic membranes, including IL-6, IL-8 and TNF-&agr;, and inhibit preterm labor and the premature rupture of fetal membranes. The practice of the method of the invention using the cytokine IL-10 is specifically described. IL-10 demonstrates the capacity to inhibit pro-inflammatory cytokine production in amniochorionic membranes in vitro as well as the capacity to inhibit uterine contractility and preterm labor in rhesus monkeys in vivo. The methods of the invention may be particularly useful in preventing infection-induced preterm labor and premature rupture of fetal membranes as well as preterm labors with a non-infectious etiology.Type: GrantFiled: January 20, 1999Date of Patent: June 11, 2002Inventors: Stephen Joseph Fortunato, Ramkumar Menon
-
Patent number: 6261791Abstract: The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, bladder cancer and bone metastasis of prostate cancer. Antibodies specific to PSCA are used for diagnosis of these cancers.Type: GrantFiled: May 25, 1999Date of Patent: July 17, 2001Assignee: The Regents of the University of CaliforniaInventors: Robert E. Reiter, Owen N. Witte
-
Patent number: 6107540Abstract: The present invention provides an immune deficient mouse having a human prostate xenograft of locally advanced or metastatic prostate cancer and uses thereof.Type: GrantFiled: October 15, 1997Date of Patent: August 22, 2000Assignee: The Regents of the University of CaliforniaInventors: Charles L. Sawyer, Karen A. Klein, Owen N. Witte, Robert E. Reiter